Group | Time point (months) | Antrum | Body | Lymphoid aggregates / follicles | GAIS | Atrophy | Submucosal inflammation | Colonisation grade | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neutrophils | CI | Neutrophils | CI | ||||||||||||||||
Non-infected | 3 | 1 (0–1) | 1 (1) | 0 (0–1) | 1 (0–1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |||||||||
6 | 0 (0–1) | 0 (0–1) | 0 (0) | 0 (0–1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||||||||||
12 | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||||||||||
18 | 0 (0) | 0 (0–1) | 0 (0) | 0 (0–1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||||||||||
Infected | 3 | 1 (1–3) | 2 (1–2) | 1.5 (0–3) | 2 (1–4) | 3.5 (0–8) | 2 (0–10) | 0 (0–2) | 1 (0–3) | 2.75 (1.5–4) | |||||||||
6 | 2 (1–2) | 2 (1–3) | 3 (1–4) | 3 (2–5) | 5 (2–11) | 7 (0–11) | 1 (0–3) | 2.5 (0–4) | 3 (1.5–3.5) | ||||||||||
12 | 2 (1–3) | 2.5 (1–3) | 3 (1–4) | 3 (2–5) | 2.5 (0–10) | 5 (0–25) | 1 (0–2) | 3 (0–5) | 3.5 (1.5–4) | ||||||||||
18 | 1 (0–4) | 2 (1–3) | 2 (0–6) | 4 (1–5) | 2 (1–10) | 8 (0–24) | 2 (0–3) | 4 (1–5) | 2.75 (0.5–4) | ||||||||||
Immunised/ challenged | 3 | 2 (1–3) | 2 (1–3) | 5 (2–5)3-150 | 3 (2–4) | 0 (0–2)3-151 | 12 (0–21)3-150 | 2.5 (1–3)3-150 | 3 (1–4) | 1 (0–2)3-151 | |||||||||
6 | 2 (1–3) | 2 (1–2) | 3 (1–4) | 3.5 (1–5) | 1 (0–5)3-151 | 8 (0–12) | 2.5 (0–3) | 3 (0–4) | 0.75 (0–3)3-151 | ||||||||||
12 | 2 (0–3) | 2 (0–3) | 1.5 (0–5) | 3.5 (0–6) | 0 (0–2)3-151 | 1 (0–3) | 2 (0–3) | 3 (0–4) | 0 (0–1)3-151 | ||||||||||
18 | 1 (0–3) | 2 (1–3) | 2 (1–3) | 4 (1–5) | 0 (0–5)3-151 | 2 (0–16) | 2 (0–3) | 3 (0–5) | 1.5 (0–4) |
CI, chronic inflammation; GAIS, gland active inflammatory score.
All scores are median (range).
↵3-150 Significantly greater than the corresponding value in the infected control group (p<0.0125; Mann-Whitney);
↵3-151 significantly lower than the corresponding value in the infected control group (p<0.0125; Mann-Whitney).